Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Colorectal Neoplasms

Free Subscription Articles published in Gut Retrieve available abstracts of 99 articles: HTML format

Single Articles

November 2024
1. RAJASEKARAN V, Harris BT, Osborn RT, Smillie C, et al
   Genetic variation at 11q23.1 confers colorectal cancer risk by dysregulation of colonic tuft cell transcriptional activator POU2AF2.
   Gut. 2024 Nov 28:gutjnl-2024-332121. doi: 10.1136/gutjnl-2024-332121.
   PubMed     Abstract available
   
   
   
2. SCHWARZMUELLER LJ, Adam RS, Moreno LF, Nijman LE, et al
   Identifying colorectal cancer-specific vulnerabilities in the Wnt-driven long non-coding transcriptome.
   Gut. 2024 Nov 19:gutjnl-2024-332752. doi: 10.1136/gutjnl-2024-332752.
   PubMed     Abstract available
   
   
   
3. SINONQUEL P, Eelbode T, Pech O, De Wulf D, et al
   Clinical consequences of computer-aided colorectal polyp detection.
   Gut. 2024;73:1974-1983.
   PubMed     Abstract available
   
   
   
4. QU R, Zhang Z, Fu W
   Potential microbial effects on microsatellite instability possibly drive divergence in colorectal cancer immunotherapy responses among different anatomical subsites.
   Gut. 2024 Nov 5:gutjnl-2024-334008. doi: 10.1136/gutjnl-2024-334008.
   PubMed    
   
   
   September 2024
5. POLYCHRONIDIS G, He MM, Vithayathil M, Knudsen MD, et al
   Risk of colorectal neoplasia after removal of conventional adenomas and serrated polyps: a comprehensive evaluation of risk factors and surveillance use.
   Gut. 2024;73:1675-1683.
   PubMed     Abstract available
   
   
   
6. MANDARINO FV, Medas R, Gauci JL, Kerrison C, et al
   Endoscopic mucosal resection for large non-pedunculated colorectal polyps: staying on track with a safe, effective and cost-efficient technique.
   Gut. 2024;73:e13.
   PubMed    
   
   
   August 2024
7. SU ACY, Ding X, Lau HCH, Kang X, et al
   Lactococcus lactis HkyuLL 10 suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidase.
   Gut. 2024;73:1478-1488.
   PubMed     Abstract available
   
   
   
8. CHEN J, Hai Y, Li Y, Wang C, et al
   Colonic multiple polypoidal protrusions: not familial adenomatous polyposis.
   Gut. 2024;73:1430-1463.
   PubMed    
   
   
   
9. DJORDJEVIC J, Cisneros Romero NS, Cascione L, Mele V, et al
   Direct toll-like receptor triggering in colorectal cancer-associated stromal cells elicits immunostimulatory properties leading to enhanced immune cell recruitment.
   Gut. 2024 Aug 8:gutjnl-2023-331759. doi: 10.1136/gutjnl-2023-331759.
   PubMed    
   
   
   July 2024
10. MAO X, Cheung KS, Tan JT, Mak LY, et al
    Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study.
    Gut. 2024;73:1313-1320.
    PubMed     Abstract available
    
    
    June 2024
11. IACUCCI M, Santacroce G, Majumder S, Morael J, et al
    Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia.
    Gut. 2024 Jun 8:gutjnl-2023-331579. doi: 10.1136/gutjnl-2023-331579.
    PubMed     Abstract available
    
    
    May 2024
12. OULADAN S, Orouji E
    Beyond traditional subtyping: a multilayered genomic perspective on colorectal cancer.
    Gut. 2024 May 15:gutjnl-2024-332325. doi: 10.1136/gutjnl-2024-332325.
    PubMed    
    
    
    April 2024
13. MEULEN LWT, Bogie RMM, Siersema PD, Winkens B, et al
    Standardised training for endoscopic mucosal resection of large non-pedunculated colorectal polyps to reduce recurrence (*STAR-LNPCP study): a multicentre cluster randomised trial.
    Gut. 2024;73:741-750.
    PubMed     Abstract available
    
    
    March 2024
14. CHEN S, Xin J, Gu D, Li H, et al
    Smoking-related Lactobacillus and immune cell infiltration in colorectal cancer: evidence from a population-based study.
    Gut. 2024 Mar 18:gutjnl-2023-331865. doi: 10.1136/gutjnl-2023-331865.
    PubMed    
    
    
    February 2024
15. ABDELRAHIM M, Siggens K, Iwadate Y, Maeda N, et al
    New AI model for neoplasia detection and characterisation in inflammatory bowel disease.
    Gut. 2024 Feb 23:gutjnl-2023-330718. doi: 10.1136/gutjnl-2023-330718.
    PubMed    
    
    
    January 2024
16. TAGHIAKBARI M, Anderson JC, von Renteln D, Hirschmann S, et al
    Extent of normal polyp resection margin: a possible quality measure for polyp resection.
    Gut. 2024;73:216-218.
    PubMed    
    
    
    
17. CORONADO GD, Jenkins CL, Shuster E, Johnson C, et al
    Blood-based colorectal cancer screening in an integrated health system: a randomised trial of patient adherence.
    Gut. 2024 Jan 4:gutjnl-2023-330980. doi: 10.1136/gutjnl-2023-330980.
    PubMed     Abstract available
    
    
    December 2023
18. DJINBACHIAN R, Pohl H, Rex DK, Levenick JM, et al
    Thermal ablation after endoscopic mucosal resection of large colorectal polyps: not only the margins, but also the base?
    Gut. 2023;73:12-15.
    PubMed    
    
    
    November 2023
19. LI R, Liu X, Huang X, Zhang D, et al
    Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis.
    Gut. 2023 Nov 30:gutjnl-2023-330243. doi: 10.1136/gutjnl-2023-330243.
    PubMed     Abstract available
    
    
    
20. POOLER BD, Kim DH, Matkowskyj KA, Newton MA, et al
    Growth rates and histopathological outcomes of small (6-9 mm) colorectal polyps based on CT colonography surveillance and endoscopic removal.
    Gut. 2023;72:2321-2328.
    PubMed     Abstract available
    
    
    
21. LUO S, Ru J, Khan Mirzaei M, Xue J, et al
    Helicobacter pylori infection alters gut virome by expanding temperate phages linked to increased risk of colorectal cancer.
    Gut. 2023 Nov 2:gutjnl-2023-330362. doi: 10.1136/gutjnl-2023-330362.
    PubMed    
    
    
    
22. DJINBACHIAN R, Khellaf A, Noyon B, Soucy G, et al
    Accuracy of measuring colorectal polyp size in pathology: a prospective study.
    Gut. 2023;72:2015-2018.
    PubMed    
    
    
    
23. TERLOUW D, Hes FJ, Suerink M, Boot A, et al
    APC mosaicism, not always isolated: two first-degree relatives with apparently distinct APC mosaicism.
    Gut. 2023;72:2186-2187.
    PubMed    
    
    
    October 2023
24. VAN DRIEL MS, Linssen JDG, van Neerven SM, Vermeulen L, et al
    Pleiotropic role of NOTUM in colorectal cancer.
    Gut. 2023 Oct 26:gutjnl-2023-330807. doi: 10.1136/gutjnl-2023-330807.
    PubMed    
    
    
    
25. TATE DJ, Desomer L, Argenziano ME, Mahajan N, et al
    Treatment of adenoma recurrence after endoscopic mucosal resection.
    Gut. 2023;72:1875-1886.
    PubMed     Abstract available
    
    
    
26. REES CJ, Hamilton W
    BSG guidelines on faecal immunochemical testing: are they 'FIT' for purpose?
    Gut. 2023;72:1805-1806.
    PubMed    
    
    
    September 2023
27. FONG W, Li Q, Ji F, Liang W, et al
    Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis.
    Gut. 2023 Sep 28:gutjnl-2023-329543. doi: 10.1136/gutjnl-2023-329543.
    PubMed     Abstract available
    
    
    
28. CHURCHHOUSE AM, Moffat VE, Selinger CP, Lamb CA, et al
    British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance.
    Gut. 2023;72:1631-1634.
    PubMed    
    
    
    
29. WINTERS C, Ford AC
    Immortal time bias in a retrospective study examining colorectal cancer mortality according to adherence to colonoscopy.
    Gut. 2023;72:1799-1800.
    PubMed    
    
    
    August 2023
30. TIAN Y, Wang X, Cramer Z, Rhoades J, et al
    APC and P53 mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer.
    Gut. 2023 Aug 17:gutjnl-2022-329140. doi: 10.1136/gutjnl-2022-329140.
    PubMed     Abstract available
    
    
    July 2023
31. KANG X, Liu C, Ding Y, Ni Y, et al
    Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells.
    Gut. 2023 Jul 25:gutjnl-2023-330291. doi: 10.1136/gutjnl-2023-330291.
    PubMed     Abstract available
    
    
    
32. BRESALIER RS, Senore C, Young GP, Allison J, et al
    An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles.
    Gut. 2023 Jul 18:gutjnl-2023-329701. doi: 10.1136/gutjnl-2023-329701.
    PubMed     Abstract available
    
    
    
33. CHAN FKL, Wong MCS, Chan AT, East JE, et al
    Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia.
    Gut. 2023;72:1240-1254.
    PubMed     Abstract available
    
    
    
34. JIANG Y, Xu Y, Zheng C, Ye L, et al
    Acetyltransferase from Akkermansia muciniphila blunts colorectal tumourigenesis by reprogramming tumour microenvironment.
    Gut. 2023;72:1308-1318.
    PubMed     Abstract available
    
    
    June 2023
35. POTENZA A, Balestrieri C, Spiga M, Albarello L, et al
    Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells.
    Gut. 2023 Jun 30:gutjnl-2022-328042. doi: 10.1136/gutjnl-2022-328042.
    PubMed     Abstract available
    
    
    
36. GAMEZ-BELMONTE R, Mahapatro M, Erkert L, Gonzalez-Acera M, et al
    Epithelial presenilin-1 drives colorectal tumour growth by controlling EGFR-COX2 signalling.
    Gut. 2023;72:1155-1166.
    PubMed     Abstract available
    
    
    May 2023
37. HAJJAR R, Fragoso G, Oliero M, Alaoui AA, et al
    Basal levels of microbiota-driven subclinical inflammation are associated with anastomotic leak in patients with colorectal cancer.
    Gut. 2023 May 3:gutjnl-2023-329929. doi: 10.1136/gutjnl-2023-329929.
    PubMed    
    
    
    
38. JUUL FE, Garborg K, Nesbakken E, Loberg M, et al
    Rates of repeated colonoscopies to clean the colon from low-risk and high-risk adenomas: results from the EPoS trials.
    Gut. 2023;72:951-957.
    PubMed     Abstract available
    
    
    April 2023
39. TOES-ZOUTENDIJK E, de Jonge L, van Iersel CA, Spaander MCW, et al
    Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis.
    Gut. 2023 Apr 19:gutjnl-2022-328559. doi: 10.1136/gutjnl-2022-328559.
    PubMed     Abstract available
    
    
    
40. RALSER A, Dietl A, Jarosch S, Engelsberger V, et al
    Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature.
    Gut. 2023 Apr 4:gutjnl-2022-328075. doi: 10.1136/gutjnl-2022-328075.
    PubMed     Abstract available
    
    
    March 2023
41. HEISSER T, Hoffmeister M, Brenner H
    Significant underestimation of preventive effects in colorectal cancer screening trial.
    Gut. 2023 Mar 7:gutjnl-2022-329165. doi: 10.1136/gutjnl-2022-329165.
    PubMed    
    
    
    
42. VON RENTELN D, Djinbachian R, Zarandi-Nowroozi M, Taghiakbari M, et al
    Measuring size of smaller colorectal polyps using a virtual scale function during endoscopies.
    Gut. 2023;72:417-420.
    PubMed    
    
    
    February 2023
43. MORGAN E, Arnold M, Gini A, Lorenzoni V, et al
    Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.
    Gut. 2023;72:338-344.
    PubMed     Abstract available
    
    
    
44. SAMADDER NJ, Foster N, McMurray RP, Burke CA, et al
    Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis.
    Gut. 2023;72:256-263.
    PubMed     Abstract available
    
    
    January 2023
45. BAO Y, Zhai J, Chen H, Wong CC, et al
    Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer.
    Gut. 2023 Jan 30:gutjnl-2022-328845. doi: 10.1136/gutjnl-2022-328845.
    PubMed     Abstract available
    
    
    
46. ROTTOLI M, Gori A, Pellino G, Flacco ME, et al
    Is the significant risk of perioperative complications associated with radical surgery following non-curative endoscopic submucosal dissection for early colorectal cancer still acceptable?
    Gut. 2023 Jan 25:gutjnl-2022-328076. doi: 10.1136/gutjnl-2022-328076.
    PubMed    
    
    
    December 2022
47. HAJJAR R, Gonzalez E, Fragoso G, Oliero M, et al
    Gut microbiota influence anastomotic healing in colorectal cancer surgery through modulation of mucosal proinflammatory cytokines.
    Gut. 2022 Dec 30:gutjnl-2022-328389. doi: 10.1136/gutjnl-2022-328389.
    PubMed     Abstract available
    
    
    
48. GIBSON DJ, Sidhu M, Zanati S, Tate DJ, et al
    Oncological outcomes after piecemeal endoscopic mucosal resection of large non-pedunculated colorectal polyps with covert submucosal invasive cancer.
    Gut. 2022;71:2481-2488.
    PubMed     Abstract available
    
    
    
49. VOSKO S, Shahidi N, Gupta S, van Hattem WA, et al
    'Fish-eye' polypectomy defect: a new sign during endoscopic mucosal resection?
    Gut. 2022;71:2413-2488.
    PubMed    
    
    
    November 2022
50. ROELANDS J, van der Ploeg M, Ijsselsteijn ME, Dang H, et al
    Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis.
    Gut. 2022 Nov 28:gutjnl-2022-327608. doi: 10.1136/gutjnl-2022-327608.
    PubMed     Abstract available
    
    
    
51. ZORZI M, Battagello J, Barbiellini Amidei C
    Reply: Immortal time bias in a retrospective study examining colorectal cancer mortality according to adherence to colonoscopy.
    Gut. 2022 Nov 4. pii: gutjnl-2022-328905. doi: 10.1136/gutjnl-2022-328905.
    PubMed    
    
    
    
52. DEY N
    Picking up microbial clues in early-onset colorectal cancer.
    Gut. 2022 Nov 2. pii: gutjnl-2022-328427. doi: 10.1136/gutjnl-2022-328427.
    PubMed    
    
    
    
53. LI C, Wang Y, Liu D, Wong CC, et al
    Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis.
    Gut. 2022;71:2253-2265.
    PubMed     Abstract available
    
    
    September 2022
54. LI X, Pan J, Liu T, Yin W, et al
    Novel TCF21(high) pericyte subpopulation promotes colorectal cancer metastasis by remodelling perivascular matrix.
    Gut. 2022 Sep 7:gutjnl-2022-327913. doi: 10.1136/gutjnl-2022-327913.
    PubMed     Abstract available
    
    
    August 2022
55. SUNG JJY, Chiu HM, Lieberman D, Kuipers EJ, et al
    Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance.
    Gut. 2022 Aug 24. pii: gutjnl-2022-327377. doi: 10.1136/gutjnl-2022-327377.
    PubMed     Abstract available
    
    
    
56. KONG C, Liang L, Liu G, Du L, et al
    Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
    Gut. 2022 Aug 11. pii: gutjnl-2022-327156. doi: 10.1136/gutjnl-2022-327156.
    PubMed     Abstract available
    
    
    July 2022
57. MONAHAN KJ, Davies MM, Abulafi M, Banerjea A, et al
    Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BS
    Gut. 2022 Jul 12. pii: gutjnl-2022-327985. doi: 10.1136/gutjnl-2022-327985.
    PubMed     Abstract available
    
    
    
58. BONNEREAU J, Courau T, Asesio N, Salfati D, et al
    Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition.
    Gut. 2022 Jul 8. pii: gutjnl-2021-326553. doi: 10.1136/gutjnl-2021-326553.
    PubMed     Abstract available
    
    
    June 2022
59. SULLIVAN KM, Jiang X, Guha P, Lausted C, et al
    Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases.
    Gut. 2022 Jun 15. pii: gutjnl-2021-325808. doi: 10.1136/gutjnl-2021-325808.
    PubMed     Abstract available
    
    
    
60. FENNELL L, Kane A, Liu C, McKeone D, et al
    Braf mutation induces rapid neoplastic transformation in the aged and aberrantly methylated intestinal epithelium.
    Gut. 2022;71:1127-1140.
    PubMed     Abstract available
    
    
    
61. NAMMOUR T, Hamie L, Barada KA
    Polyps and skin lesions: what could it be?
    Gut. 2022;71:1061-1116.
    PubMed    
    
    
    May 2022
62. MEESTER RGS, van de Schootbrugge-Vandermeer HJ, Breekveldt ECH, de Jonge L, et al
    Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model.
    Gut. 2022 May 10. pii: gutjnl-2022-327188. doi: 10.1136/gutjnl-2022-327188.
    PubMed     Abstract available
    
    
    
63. BUZIAU AM, Law PJ, Blokland G, Schalkwijk C, et al
    Genetically proxied ketohexokinase function and risk of colorectal cancer: a Mendelian randomisation study.
    Gut. 2022 May 10. pii: gutjnl-2021-326299. doi: 10.1136/gutjnl-2021-326299.
    PubMed    
    
    
    
64. ASLAN J, Conley TE, Campbell F, Smith PJ, et al
    Recurrent colonic polyps.
    Gut. 2022;71:888-960.
    PubMed    
    
    
    April 2022
65. CORRY SM, McCorry AM, Lannagan TR, Leonard NA, et al
    Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer.
    Gut. 2022 Apr 27. pii: gutjnl-2021-326183. doi: 10.1136/gutjnl-2021-326183.
    PubMed     Abstract available
    
    
    
66. WALJEE AK, Weinheimer-Haus EM, Abubakar A, Ngugi AK, et al
    Artificial intelligence and machine learning for early detection and diagnosis of colorectal cancer in sub-Saharan Africa.
    Gut. 2022 Apr 13. pii: gutjnl-2022-327211. doi: 10.1136/gutjnl-2022-327211.
    PubMed    
    
    
    
67. JESS T, Vestergaard MV, Iversen AT, Allin KH, et al
    Undiagnosed inflammatory bowel disease among individuals undergoing colorectal cancer screening: a nationwide Danish cohort study 2014-2018.
    Gut. 2022 Apr 12. pii: gutjnl-2022-327296. doi: 10.1136/gutjnl-2022-327296.
    PubMed    
    
    
    
68. BAI X, Wei H, Liu W, Coker OO, et al
    Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites.
    Gut. 2022 Apr 6. pii: gutjnl-2021-325021. doi: 10.1136/gutjnl-2021-325021.
    PubMed     Abstract available
    
    
    
69. REPICI A, Spadaccini M, Antonelli G, Correale L, et al
    Artificial intelligence and colonoscopy experience: lessons from two randomised trials.
    Gut. 2022;71:757-765.
    PubMed     Abstract available
    
    
    
70. JIMENEZ-VARGAS NN, Yu Y, Jensen DD, Bok DD, et al
    Agonist that activates the micro-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.
    Gut. 2022;71:695-704.
    PubMed     Abstract available
    
    
    
71. HO JL, Vu C, Liang R, Ding C, et al
    Not your 'day-to-day' colonic polyps.
    Gut. 2022;71:675-715.
    PubMed    
    
    
    March 2022
72. HALLIT R, Barret M, Belle A, Abou Ali E, et al
    Appendoscopy in patients with serrated polyposis syndrome.
    Gut. 2022;71:653-654.
    PubMed    
    
    
    
73. HOUWEN BBSL, Hazewinkel Y, Pellise M, Rivero-Sanchez L, et al
    Linked Colour imaging for the detection of polyps in patients with Lynch syndrome: a multicentre, parallel randomised controlled trial.
    Gut. 2022;71:553-560.
    PubMed     Abstract available
    
    
    
74. PAGANO E, Elias JE, Schneditz G, Saveljeva S, et al
    Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment.
    Gut. 2022;71:509-520.
    PubMed     Abstract available
    
    
    
75. SI W, Liang H, Bugno J, Xu Q, et al
    Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade.
    Gut. 2022;71:521-533.
    PubMed     Abstract available
    
    
    February 2022
76. DHAWAN R, Shay D, Zhao YC, Lu Y, et al
    Comment on Murphy et al: maternal obesity, pregnancy weight gain, and birth weight and risk of colorectal cancer.
    Gut. 2022 Feb 23. pii: gutjnl-2022-327148. doi: 10.1136/gutjnl-2022-327148.
    PubMed    
    
    
    
77. ALDOORI J, Cockbain AJ, Toogood GJ, Hull MA, et al
    Omega-3 polyunsaturated fatty acids: moving towards precision use for prevention and treatment of colorectal cancer.
    Gut. 2022 Feb 3. pii: gutjnl-2021-326362. doi: 10.1136/gutjnl-2021-326362.
    PubMed     Abstract available
    
    
    
78. 
    Correction: Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246/92b-3p/27a-3p and CXCL16.
    Gut. 2022;71:e1-e3.
    PubMed    
    
    
    
79. GUAN H, Zeng C, Chen Y
    Letter to editor: piecemeal cold snare polypectomy versus conventional endoscopic mucosal resection for large sessile serrated lesions.
    Gut. 2022;71:440.
    PubMed    
    
    
    
80. HUANG TX, Tan XY, Huang HS, Li YT, et al
    Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity.
    Gut. 2022;71:333-344.
    PubMed     Abstract available
    
    
    January 2022
81. TIAN S, Chu Y, Hu J, Ding X, et al
    Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT.
    Gut. 2022 Jan 27. pii: gutjnl-2021-325137. doi: 10.1136/gutjnl-2021-325137.
    PubMed     Abstract available
    
    
    
82. SPADACCINI M, Bourke MJ, Maselli R, Pioche M, et al
    Clinical outcome of non-curative endoscopic submucosal dissection for early colorectal cancer.
    Gut. 2022 Jan 20. pii: gutjnl-2020-323897. doi: 10.1136/gutjnl-2020-323897.
    PubMed     Abstract available
    
    
    December 2021
83. DONG C, Lee YH, Tan TY, Yao CC, et al
    Correspondence to proton pump inhibitors and risk of colorectal cancer.
    Gut. 2021 Dec 2. pii: gutjnl-2021-326139. doi: 10.1136/gutjnl-2021-326139.
    PubMed    
    
    
    
84. ABRAHAMI D, Azoulay L
    Response by Abrahami et al to letter regarding article 'Proton pump inhibitors and risk of colorectal cancer'.
    Gut. 2021 Dec 2. pii: gutjnl-2021-326544. doi: 10.1136/gutjnl-2021-326544.
    PubMed    
    
    
    
85. CHIU HM, Jen GH, Wang YW, Fann JC, et al
    Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers.
    Gut. 2021;70:2321-2329.
    PubMed     Abstract available
    
    
    November 2021
86. CASH BD, Fleisher MR, Fern S, Rajan E, et al
    Multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study).
    Gut. 2021;70:2115-2122.
    PubMed     Abstract available
    
    
    October 2021
87. KRYKLYVA V, Luchini C, Stommel MWJ, Nagtegaal ID, et al
    Detecting Lynch syndrome in pancreatic ductal adenocarcinoma FNA cytology based on cancer history and immunocytochemistry.
    Gut. 2021 Oct 19. pii: gutjnl-2021-326033. doi: 10.1136/gutjnl-2021-326033.
    PubMed    
    
    
    September 2021
88. KANDIAH K, Subramaniam S, Thayalasekaran S, Chedgy FJ, et al
    Multicentre randomised controlled trial on virtual chromoendoscopy in the detection of neoplasia during colitis surveillance high-definition colonoscopy (the VIRTUOSO trial).
    Gut. 2021;70:1684-1690.
    PubMed     Abstract available
    
    
    July 2021
89. OSTER P, Vaillant L, Riva E, McMillan B, et al
    Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies.
    Gut. 2021 Jul 12. pii: gutjnl-2020-323392. doi: 10.1136/gutjnl-2020-323392.
    PubMed     Abstract available
    
    
    
90. WALDMANN E, Penz D, Sinkovec H, Heinze G, et al
    Interval cancer after colonoscopy in the Austrian National Screening Programme: influence of physician and patient factors.
    Gut. 2021;70:1309-1317.
    PubMed     Abstract available
    
    
    
91. SHAHIDI N, van Hattem WA, Vosko S, Bourke MJ, et al
    Don't judge a book by its cover: except during optical evaluation.
    Gut. 2021;70:1252-1286.
    PubMed    
    
    
    June 2021
92. IMPERIALE TF, Monahan PO, Stump TE, Ransohoff DF, et al
    Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults.
    Gut. 2021;70:1155-1161.
    PubMed     Abstract available
    
    
    May 2021
93. RUTTER MD, Evans R, Hoare Z, Von Wagner C, et al
    WASh multicentre randomised controlled trial: water-assisted sigmoidoscopy in English NHS bowel scope screening.
    Gut. 2021;70:845-852.
    PubMed     Abstract available
    
    
    
94. BIBAULT JE, Chang DT, Xing L
    Development and validation of a model to predict survival in colorectal cancer using a gradient-boosted machine.
    Gut. 2021;70:884-889.
    PubMed     Abstract available
    
    
    
95. LO PRESTI E, Corsale AM, Di Simone M, Dieli F, et al
    Characterisation of gammadelta T cells infiltrating colorectal cancer.
    Gut. 2021;70:1001-1003.
    PubMed    
    
    
    April 2021
96. ZHAO R, Wan QY, Wu Y, Wang Y, et al
    Crohn's disease instead of UC might increase the risk of small bowel cancer.
    Gut. 2021;70:809-810.
    PubMed    
    
    
    March 2021
97. SIRINUKUNWATTANA K, Domingo E, Richman SD, Redmond KL, et al
    Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
    Gut. 2021;70:544-554.
    PubMed     Abstract available
    
    
    
98. REYES-URIBE L, Wu W, Gelincik O, Bommi PV, et al
    Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa.
    Gut. 2021;70:555-566.
    PubMed     Abstract available
    
    
    September 2020
99. GRANT RC, Denroche R, Jang GH, Nowak KM, et al
    Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
    Gut. 2020 Sep 15. pii: gutjnl-2020-320730. doi: 10.1136/gutjnl-2020-320730.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.